Please join us on Thursday, September 15 at 5:00 pm EST (4:00 pm CST/2:00 pm PST) for a webinar about the HEALEY ALS Platform Trial. Sabrina Paganoni, MD, PhD and Merit Cudkowicz, MD, MSc will present updates on the Platform Trial and answer questions from the audience. In addition, this week will feature a special introduction to Site Investigator Tawfiq Al-Lahham, MD at UPMC in Pennslyvania
In addition to serving as a Site Investigator for the Platform Trial, Dr. Al-Lahham is the Director of the MDA-ALS Center at the University of Pittsburgh. The goals of his research are to identify the processes that cause motor neuron degeneration and to find novel therapeutic interventions.